

Author: Santos Robson AS Ferreira Anderson J Pinheiro Sérgio VB Sampaio Walkyria O Touyz Rhian Campagnole-Santos Maria José
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.14, Iss.8, 2005-08, pp. : 1019-1031
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Molecular Targets of Diabetic Vascular Complications and Potential New Drugs
Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. :




New Targets for Antithrombotic Drugs
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. :